AIPOD CV 325 is a combination antibiotic formulation containing Cefpodoxime Proxetil and Potassium Clavulanate, designed to provide effective treatment against a wide range of bacterial infections. This advanced dual-action therapy combines the bactericidal action of Cefpodoxime with the resistance-fighting benefits of Clavulanic Acid, offering enhanced antibacterial coverage against susceptible and resistant bacterial strains.

Cefpodoxime works by destroying bacteria through inhibition of cell wall formation, while Potassium Clavulanate protects the antibiotic from bacterial enzymes that can reduce its effectiveness, thereby improving treatment outcomes.

Key Benefits

• Broad-spectrum antibacterial protection.
• Effective against a wide range of bacterial infections.
• Helps overcome bacterial resistance mechanisms.
• Enhances the effectiveness of antibiotic therapy.
• Supports faster recovery from infection-related symptoms.
• Suitable for respiratory, urinary, skin, ear, and throat infections.

Therapeutic Uses

Respiratory Tract Infections

• Bronchitis
• Pneumonia
• Other bacterial respiratory infections

Ear, Nose & Throat Infections

• Sinusitis
• Tonsillitis
• Pharyngitis
• Ear Infections (Otitis Media)

Helps relieve infection, inflammation, and associated discomfort.

Urinary Tract Infections (UTIs)

• Bladder infections
• Kidney infections
• Other bacterial urinary tract infections

Skin & Soft Tissue Infections

• Infected wounds
• Skin infections
• Soft tissue bacterial infections

Uncomplicated Gonorrhea

• Used for the treatment of susceptible uncomplicated gonococcal infections as prescribed by a healthcare professional.

How It Works

Cefpodoxime Proxetil

• A third-generation cephalosporin antibiotic that kills bacteria by preventing the formation of their protective cell walls, which are essential for their growth and survival.

Potassium Clavulanate

• A beta-lactamase inhibitor that helps reduce bacterial resistance and enhances the antibacterial activity of Cefpodoxime against bacteria that may otherwise inactivate the antibiotic.

Composition

• Cefpodoxime Proxetil IP
• Potassium Clavulanate IP
• Equivalent to AIPOD CV 325

Important Information

• Effective only against bacterial infections.
• Not suitable for viral illnesses such as the common cold or influenza.
• Patients should complete the full prescribed course of treatment even if symptoms improve early, to ensure complete eradication of bacteria and help prevent antibiotic resistance.

AIPOD CV 325 Tablets provide reliable broad-spectrum antibacterial therapy, helping ensure effective infection management, faster recovery, and improved patient well-being.